| Pharmaceutical active ingredients: |
| Calcium DobesilateDexamethasone AcetateLidocaine Hydrochloride |
| Available forms, composition and doses of Doxiproct mit Dexamethason: |
| Ointment; Topical; Calcium Dobesilate 4%; Dexamethasone Acetate 0.0025%; Lidocaine Hydrochloride 2% |
| Doxiproct mit Dexamethason medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C05BX01 - Calcium DobesilateR01AD53 - Dexamethasone, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Ebewe |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dobkair | Calcium Dobesilate Monohydrate | PDC Healthcare |
| Dosil | Calcium Dobesilate Monohydrate | BioMedica Life Sciences |
| Danium Compositum | Calcium Dobesilate; Carboxymethyl Cellulose Calcium; Zinc Oxide | Zentiva |
| Ederal | Calcium Dobesilate; Cinnarizine | Esteve Farma |
| Vasodual | Calcium Dobesilate; Cinnarizine | Janssen |
| Doxiproct Plus | Calcium Dobesilate; Dexamethasone Acetate; Lidocaine Hydrochloride | OM Pharma; Pharmedial |
| Doxivenil | Calcium Dobesilate; Dextran Sulfate Potassium | Teva; Delalande Isnardi Laboratori; Leti Laboratorios; OM Pharma; Pharmedial |
| Swift | Calcium Dobesilate; Docusate Calcium | Invision Medi Sciences |
| Smuth Capsules | Calcium Dobesilate; Docusate Sodium | Aristo Pharmaceuticals |
| Dobexil Plus | Calcium Dobesilate; Hydrocortisone Acetate; Lidocaine Hydrochloride | Zentiva |